Creative Peptides
This peptide sequence represents residues 395-430 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 395-430 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 523-541 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence represents residues 523-541 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 438-458 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 450-473 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 450-473 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 480-496 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 480-496 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 500-509 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.
More Information
Supplier Page
Creative Peptides
This peptide sequence has residues 500-509 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-LC at the C-terminus.
More Information
Supplier Page
Creative Peptides
Identified from in silico studies, the set of 6 peptides offered are unique T-cell epitopes from the SARS-CoV-2 spike protein sequence. The peptide sequences are offered in net peptide quantities in individual vials of 0.25 mg each. The sequences in the set are,CV2-1 YLQPRTFLL CV2-2 GVYFASTEK CV2-3 KLPDDFTGCV CV2-4 SIIAYTMSL CV2-5 NYNYLYRLFR CV2-6 GYLQPRTFLL
More Information
Supplier Page
Creative Peptides
Scrambled 10Panx, scrambled version of 10panx, is a Panx-1 mimetic inhibitory peptide that blocks pannexin-1 gap junctions.
More Information
Supplier Page
Creative Peptides
Scyliorhinin II is a selective neurokinin-3 receptor agonist, with a Ki of 2.5 nM for neurokinin-3 receptor in rat cerebral cortex.
More Information
Supplier Page
SDGRG
Inquiry
| >95%
Creative Peptides
